Aligned Genetics, Inc. (KOSDAQ: 238120)

Market Cap	44.00B
Revenue (ttm)	14.93B
Net Income (ttm)	3.31B
Shares Out	14.38M
EPS (ttm)	184.29
PE Ratio	16.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,326
Open	2,880.00
Previous Close	2,955.00
Day's Range	2,880.00 - 3,100.00
52-Week Range	2,880.00 - 12,350.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Aligned Genetics

Aligned Genetics, Inc., a biotech company, develops, manufactures, and sells imaging solutions for research institutions worldwide. The company offers solutions for digital cell imaging, and tissue clearing and 3D imaging. It offers its solutions through distributors. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-si, South Korea.

• Industry: Laboratory Analytical Instruments
• Founded: 2008
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 238120

Financial Performance

In 2023, Aligned Genetics's revenue was 15.21 billion, an increase of 10.63% compared to the previous year's 13.75 billion. Earnings were 3.24 billion, an increase of 38.72%.